February 2026: R01 Renewal Awarded
With this renewal, we will leverage human proteogenomics, engineered adipocyte depot models, and in vivo adipose-specific proteomics to discover and
With this renewal, we will leverage human proteogenomics, engineered adipocyte depot models, and in vivo adipose-specific proteomics to discover and